Glecaprevir/pibrentasvir
Dispensed in May 2025
Rolling 12 months
Net ingredient cost · May 2025
Figure 1. Glecaprevir/pibrentasvir: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2025
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Antiviral drugs
- Presentations 1 shown
- Average cost / item £3,248.42
Top presentations, May 2025
The individual products dispensed under Glecaprevir/pibrentasvir this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Glecaprevir 100mg / Pibrentasvir 40mg tablets | 0503032K0AAAAAA | 8 | £25,987 |
Source: NHSBSA Prescription Cost Analysis · to May 2025 OGL v3.0
Where Glecaprevir/pibrentasvir is dispensed
The regions and dispensing practices with the highest Glecaprevir/pibrentasvir volumes.
Top regions
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Glecaprevir/pibrentasvir with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Glecaprevir/pibrentasvir is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.